|
Volumn 12, Issue 4, 2011, Pages 319-321
|
MicroRNA therapeutics in preclinical cancer models
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMICRORNA 122;
BIM PROTEIN;
CYCLIN D2;
CYCLIN E;
ERLOTINIB;
IMATINIB;
K RAS PROTEIN;
MICRORNA;
MICRORNA 10B;
MICRORNA 16;
MICRORNA 26A;
MICRORNA 31;
MICRORNA INHIBITOR;
MICRORNA LET 7;
PROTEIN KINASE B;
SHORT HAIRPIN RNA;
UNCLASSIFIED DRUG;
BONE METASTASIS;
BREAST CANCER;
CANCER GENE THERAPY;
CANCER MODEL;
CANCER MORTALITY;
CANCER PATIENT;
CELL PROLIFERATION;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG TOLERABILITY;
GENE EXPRESSION;
HEPATITIS C;
HUMAN;
LETTER;
LIVER TUMOR;
LUNG METASTASIS;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METASTASIS;
NECROSIS;
NEOPLASM;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
TUMOR GROWTH;
TUMOR PROMOTION;
GENE THERAPY;
HUMANS;
MICRORNAS;
NEOPLASMS;
|
EID: 79953203557
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(11)70067-5 Document Type: Letter |
Times cited : (49)
|
References (10)
|